Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 655 results for "f hoffmann la roche ltd"

Hormone Refractory Breast Cancer Global Clinical Trials Review, H1,...
PRWeb

Global Imaging Biomarkers Market 2014-2018 with Abbott, Agilen...

Research and Markets (http://www.researchandmarkets.com/research/brn9sx/global_imaging) has announced the addition of the "" report to their offering. The use of imaging biomarkers in the field of drug discovery has increased considerably over the ... Individual.com, 1 month ago
[x]  

5 images for f hoffmann la roche ltd

PR inside, 1 week ago
4 Traders, 2 months ago
Drug Discovery and Development, 4 months ago
Drug Discovery and Development, 5 months ago
4 Traders, 5 months ago

Roche receives EC approval for non-Hodgkin Lymphoma drug

F. Hoffmann-La Roche Ltd has received the European Commission, or EC, approval for a new subcutaneous, or SC, formulation of MabThera indicated for the treatment of patients with follicular lymphoma and diffuse large B-cell lymphoma, two common ...
 Individual.com2 weeks ago Roche receives CE mark for new version of HIV diagnostic test  Individual.com1 month ago

Roche launches new cytology test for cervical precancer detection

F. Hoffmann-La Roche Ltd has launched a fully automated CINtec PLUS cytology test to improve the detection and early intervention of precancerous cervical disease. The CINtec PLUS cytology test helps identify women with high-grade precancerous ...
 Individual.com1 month ago

ROCHE BEARER SHARE : CHUGAI -F. Hoffmann-La Roche Announces First Quarter Sales 2014

Release date- 15042014 - F. Hoffmann-La Roche Ltd. (hereafter 'Roche') [Head Office: Basel, Switzerland . CEO: Severin Schwan ] announced today its first quarter sales 2014 ( January 1 - March 31, 2014 ). Roche owns 59.9% of Chugai's outstanding ...
 4 Traders3 days ago CHUGAI PHARMACEUTICAL : F. Hoffmann-La Roche Announces First Quarter Sales 2014  4 Traders5 days ago ROCHE HOLDING LTD. (BEARER SHARE) : Hoffmann-La Roche Inc. Assigned Patent  4 Traders1 month ago

Recent Findings from F. Hoffmann-La Roche Has Provided New Information about Nanoparticles

By a News Reporter-Staff News Editor at Life Science Weekly -- Fresh data on Nanoparticles are presented in a new report. According to news reporting originating in Basel, Switzerland , by NewsRx journalists, research stated, "Melittin is an ...
 4 Traders3 weeks ago Investigators from F. Hoffmann-La Roche Have Reported New Data on Circadian Rhythms  4 Traders1 month ago Findings from G. Quebatte and Colleagues Update Understanding of DNA Research  HispanicBusiness.com1 month ago

Tanabe to Launch AIDS-related "VALIXA Tablets 450 mg"

VALIXA Tablets 450 mg is a pro-drug preparation of ganciclovir, which was developed by F. Hoffmann-La Roche AG (Basel, Switzerland). In clinical trials carried out overseas, it has proven to be highly efficacious in treatment of CMV retinitis (both ...
 Web Newswire1 month ago

Chugai Pharmaceutical launches breast cancer drug

Chugai Pharmaceutical Co., Ltd. has launched Kadcyla Intravenous Infusion 100mg and 160mg, an anti-HER2 antibody-tubulin polymerization inhibitor conjugate, indicated for the treatment of HER2-positive inoperable or recurrent breast cancer. Kadcyla ...
 Individual.com1 day ago Chugai Pharmaceutical files new drug application for melanoma drug  Individual.com6 days ago CHUGAI PHARMACEUTICAL : Launch of the Anti-Cancer Agent Kadcyla®  4 Traders3 days ago

PDL BioPharma Announces Agreement with Genentech and Roche to Settle Litigation and Arbitration

INCLINE VILLAGE, Nev. , Feb. 3, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has entered into an agreement with Genentech, Inc. (Genentech) and F. Hoffmann-La Roche Ltd. (Roche) which resolves all ...
 Asian Hospital & Healthcare Management2 months ago

Australian Competition and Consumer Commission v SensaSlim Australia Pty Ltd (in liq) (No 5) [2014] FCA 340

AUSTRALIAN COMPETITION AND CONSUMER COMMISSION v SENSASLIM AUSTRALIA PTY LTD (IN LIQUIDATION) ACN 140 333 133, PETER CLARENCE FOSTER, PETER LESLIE O'BRIEN, ADAM TROY ADAMS and MICHAEL ANTHONY BOYLE File number: YATES J Date of judgment: 8 ...
 Federal Court of Australia1 week ago

Market Report, "Systemic Lupus Erythematosus - Pipeline Review, H1 2014", Published

recommends "Systemic Lupus Erythematosus - Pipeline Review, H1 2014" from Global Markets Direct, now available Boston, MA -- (SBWIRE) -- 04/16/2014 -- Global Markets Direct's, 'Systemic Lupus Erythematosus - Pipeline Review, H1 2014', provides an ...
 Digital Journal3 days ago New Market Study, "Osteoporosis - Pipeline Review, H1 2014", Has Been Published  Digital Journal3 days ago Rheumatoid Arthritis - Pipeline Review, H1 2014: New Research Report Available at Fast Market Research  Digital Journal3 days ago New Report Available: Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H1 2014  Digital Journal4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less